Adherence Rates For Peginterferon + Ribavirin Compared With Telaprevir + Peginterferon + Ribavirin In Medicaid And Commercial Patients Treated For Chronic Hepatitis C

Autor:	S. Manthena, Jennifer C. Samp, Timothy Juday, D. Walker
Rok vydání:	2016
Předmět:	medicine.medical_specialty Chronic hepatitis business.industry Internal medicine Health Policy medicine Public Health Environmental and Occupational Health PEGINTERFERON/RIBAVIRIN business Gastroenterology Medicaid Telaprevir medicine.drug
Zdroj:	Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(7)
ISSN:	1524-4733
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c998bd12bee36faf7d9e46470560b34 https://pubmed.ncbi.nlm.nih.gov/27200776 Zobrazit plný text záznamu Full Text from ScienceDirect